US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 2026202520242023
Class II · Moderate risk Ongoing

Papaverine/Phentolamine/Prostaglandin Inj 150mg/5mg/10mcg/Vial Solution

Reason Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

Pharmacy Plus, Inc. dba Vital Care Compounder D-0049-2023
Class II · Moderate risk Ongoing

Papaverine/Phentolamine/Prostaglandin Inj 150/5/50mcg / Vial Solution

Reason Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

Pharmacy Plus, Inc. dba Vital Care Compounder D-0048-2023
Class II · Moderate risk Ongoing

Papaverine HCL Stock Solution 30mg/Ml Solution

Reason Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

Pharmacy Plus, Inc. dba Vital Care Compounder D-0047-2023
Class II · Moderate risk Ongoing

Papaverine / Phentolamine Injection 150mg / 5mg / Vial Solution

Reason Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

Pharmacy Plus, Inc. dba Vital Care Compounder D-0046-2023
Class II · Moderate risk Ongoing

Papaverine / Phentolamine / Prostaglandin 150mg / 2.5mg / 50mcg Solution

Reason Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

Pharmacy Plus, Inc. dba Vital Care Compounder D-0042-2023
Class II · Moderate risk Ongoing

PAP/PHEN/PROSTAG/ATROPINE INJ 150MG/7.5MG/75MCG/1MG bottle solution

Reason Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

Pharmacy Plus, Inc. dba Vital Care Compounder D-0041-2023
Class II · Moderate risk Ongoing

Moxifloxacin Preservative Free Syr

Reason Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

Pharmacy Plus, Inc. dba Vital Care Compounder D-0040-2023
Class II · Moderate risk Ongoing

MITOMYCIN INJECTION 0.375 mg/mL SYR

Reason Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

Pharmacy Plus, Inc. dba Vital Care Compounder D-0039-2023
Class II · Moderate risk Ongoing

METHYLCOBALAMIN PF 1 ML Injection Solution 5

Reason Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

Pharmacy Plus, Inc. dba Vital Care Compounder D-0038-2023
Class II · Moderate risk Ongoing

MEDROXYPROGESTERONE ACETATE 300 MG/ML Suspension

Reason Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

Pharmacy Plus, Inc. dba Vital Care Compounder D-0037-2023
Class II · Moderate risk Ongoing

LIDOCAINE EPINEPHRINE BUFFERED 2%/1:1000 Solution

Reason Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

Pharmacy Plus, Inc. dba Vital Care Compounder D-0036-2023
Class II · Moderate risk Ongoing

LIDOCAINE/PHENYLEPHRINE PF SYR 1%/1.5% Solution

Reason Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

Pharmacy Plus, Inc. dba Vital Care Compounder D-0035-2023
Class II · Moderate risk Ongoing

LAURETH-9 INJ 2% Solution

Reason Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

Pharmacy Plus, Inc. dba Vital Care Compounder D-0034-2023
Class II · Moderate risk Ongoing

GLYCERIN OPHTHALMIC DROPS 98.5% Solution

Reason Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

Pharmacy Plus, Inc. dba Vital Care Compounder D-0033-2023
Class II · Moderate risk Ongoing

CYCLOSPORIN 0.07% OPTH 0.07% Solution in 10 mL bottles

Reason Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

Pharmacy Plus, Inc. dba Vital Care Compounder D-0032-2023
Class II · Moderate risk Ongoing

CEFUROXIME INTRAVITREAL SYR 1MG/0.1ML Solution in 1 mL syringe

Reason Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

Pharmacy Plus, Inc. dba Vital Care Compounder D-0031-2023
Class II · Moderate risk Ongoing

CEFTAZIDIME INTRAVITREAL 2.25MG/0.1ML Solution

Reason Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

Pharmacy Plus, Inc. dba Vital Care Compounder D-0030-2023
Class II · Moderate risk Ongoing

Brilliant Blue G

Reason Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

Pharmacy Plus, Inc. dba Vital Care Compounder D-0029-2023
Class II · Moderate risk Ongoing

Autologus Tears Serum Soln Full Strength

Reason Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

Pharmacy Plus, Inc. dba Vital Care Compounder D-0028-2023
Class II · Moderate risk Ongoing

ACETYLCYSTEINE OPTH 5% Solution

Reason Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

Pharmacy Plus, Inc. dba Vital Care Compounder D-0027-2023
Class II · Moderate risk Ongoing

ACETYLCYSTEINE OPTH 10% Solution

Reason Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

Pharmacy Plus, Inc. dba Vital Care Compounder D-0026-2023
Class II · Moderate risk Ongoing

SIREtizer Hand Sanitizer

Reason CGMP Deviations and Superpotent Drug: Levels of acetal and acetaldehyde above allowable limits. Additionally, lot 001 was superpotent.

Southwest Iowa Renewable Energy LLC D-0166-2023